Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma (BHP RCC): A Distinctive Neoplasm Associated With Somatic NF2 Mutations.
Journal
The American journal of surgical pathology
ISSN: 1532-0979
Titre abrégé: Am J Surg Pathol
Pays: United States
ID NLM: 7707904
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
pubmed:
29
3
2020
medline:
22
10
2020
entrez:
29
3
2020
Statut:
ppublish
Résumé
We report 8 cases of a distinctive, previously undescribed renal cell carcinoma associated with somatic mutations in the neurofibromin 2 (NF2) gene. All patients were adults, ranging from 51 to 78 years of age and of cases of known sex 6 of 7 were males. The carcinomas were predominantly unencapsulated, and all had a rounded, nodular interface with the native kidney. The neoplasms were all solid with papillary architecture evident in most cases (7/8), while 1 was only tubular. All cases were biphasic, characterized by larger and smaller carcinoma cells. The smaller cells clustered around basement membrane material similar to the characteristic pattern of the t(6;11) renal cell carcinoma associated with TFEB gene fusions. In 6 of 8 carcinomas, branching nodules of small cells clustered around basement membrane material within larger acini yielding a distinctive glomeruloid pattern. In 6 of 8 carcinomas, the small cells were focally spindle-shaped and unassociated with the basement membrane material. The stroma was sclerotic in all 8 carcinomas, and all 8 contained psammoma bodies that were abundant in 2. In some carcinomas, focal or predominant areas had a less distinctive appearance; 2 had areas that resembled clear cell renal cell carcinoma, 2 had high-grade eosinophilic areas, while 1 had branching tubular architecture that resembled mucinous tubular and spindle cell carcinoma. Two carcinomas demonstrated cellular necrosis. Although we have minimal clinical follow-up, 1 case presented with distant metastasis, progressed and resulted in patient death. While NF2 mutations may be found in other established renal cell carcinoma subtypes (often as secondary genetic alterations), they are potentially the genetic driver of this distinctive entity.
Identifiants
pubmed: 32217839
doi: 10.1097/PAS.0000000000001467
pmc: PMC7350624
mid: NIHMS1567486
pii: 00000478-202007000-00011
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
901-916Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA193145
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
Am J Surg Pathol. 2003 Jun;27(6):750-61
pubmed: 12766578
N Engl J Med. 2016 Jan 14;374(2):135-45
pubmed: 26536169
Am J Surg Pathol. 2013 Jan;37(1):74-80
pubmed: 23211287
Am J Pathol. 2001 Jul;159(1):179-92
pubmed: 11438465
Virchows Arch. 2018 Dec;473(6):725-738
pubmed: 30232607
Am J Surg Pathol. 2019 Jan;43(1):121-131
pubmed: 30303819
Nature. 2013 Jul 4;499(7456):43-9
pubmed: 23792563
Hum Pathol. 2010 Jul;41(7):1051-2; author reply 1052
pubmed: 20434192
Am J Surg Pathol. 2017 May;41(5):655-662
pubmed: 28296677
Am J Surg Pathol. 2013 Aug;37(8):1150-63
pubmed: 23715164
Am J Surg Pathol. 2018 Sep;42(9):1166-1181
pubmed: 29975249
Am J Surg Pathol. 2012 Oct;36(10):1516-26
pubmed: 22892601
Cancer Discov. 2016 Nov;6(11):1258-1266
pubmed: 27604489
Expert Opin Ther Pat. 2018 Dec;28(12):867-873
pubmed: 30482112
Eur Urol. 2016 Sep;70(3):516-21
pubmed: 26149668
Am J Surg Pathol. 2016 Jun;40(6):723-37
pubmed: 26975036
Nat Commun. 2016 Oct 07;7:13131
pubmed: 27713405
Mod Pathol. 1997 Jun;10(6):537-44
pubmed: 9195569
Am J Surg Pathol. 2005 Feb;29(2):230-40
pubmed: 15644781
Oncogene. 2016 Feb 4;35(5):537-48
pubmed: 25893302
Oncogene. 2004 Nov 4;23(52):8447-54
pubmed: 15378014
Pathology. 2018 Feb;50(2):141-150
pubmed: 29269124
Nat Med. 2017 Jun;23(6):703-713
pubmed: 28481359
Am J Surg Pathol. 2018 Jul;42(7):911-917
pubmed: 29668487
Clin Genitourin Cancer. 2019 Aug;17(4):268-274.e1
pubmed: 31151928
Am J Pathol. 2001 Jun;158(6):2089-96
pubmed: 11395386
J Mol Diagn. 2017 Jan;19(1):4-23
pubmed: 27993330
Mod Pathol. 2015 Nov;28(11):1504-14
pubmed: 26336887
Hum Pathol. 2009 Nov;40(11):1650-4
pubmed: 19540552
Sci Rep. 2020 Jan 20;10(1):701
pubmed: 31959902
Am J Surg Pathol. 2014 Dec;38(12):1588-602
pubmed: 25025441
Clin Kidney J. 2013 Aug;6(4):426-428
pubmed: 25352984
Nat Rev Cancer. 2013 Apr;13(4):246-57
pubmed: 23467301
Am J Surg Pathol. 2002 Dec;26(12):1553-66
pubmed: 12459622
Eur Urol. 2018 Oct;74(4):483-486
pubmed: 29941307